Cambridge Investment Research Advisors’s Mesoblast MESO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,146	Closed	-$110K	–	3799
2025 Q2	$110K	Sell	10,146 -1,264	-11%	-$14.2K	﹤0.01%	3461
2025 Q1	$142K	Buy	11,410 +150	+1%	+$2.47K	﹤0.01%	3285
2024 Q4	$223K	Buy	11,260 +260	+2%	+$2.88K	﹤0.01%	3103
2024 Q3	$90K	Sell	11,000 -1,500	-12%	-$10.2K	﹤0.01%	3280
2024 Q2	$85K	Buy	+12,500	New	+$85.5K	﹤0.01%	3176
2022 Q2	–	Sell	-5,500	Closed	-$46K	–	3154
2022 Q1	$46K	Hold	5,500	–	–	﹤0.01%	3083
2021 Q4	$53K	Hold	5,500	–	–	﹤0.01%	3099
2021 Q3	$66K	Buy	+5,500	New	+$76.3K	﹤0.01%	3005

Other funds holding MESO

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Cambridge Investment Research Advisors's MESO Position: Q3 2025 in Review

Cambridge Investment Research Advisors sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 10,146 shares — an estimated $110K sold.

Cambridge Investment Research Advisors first reported a position in MESO in Q3 2021 and held it in 8 quarters. The position peaked at $223K in Q4 2024. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

Cambridge Investment Research Advisors reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
Cambridge Investment Research Advisors sold 10,146 Mesoblast shares in Q3 2025, an estimated $110K.
Cambridge Investment Research Advisors first reported a position in Mesoblast in Q3 2021 and held it in 8 quarters.
Cambridge Investment Research Advisors's Mesoblast position peaked at $223K in Q4 2024.
68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.